London penthouses ‘owned’ by Iran’s supreme leader go up for sale
They are located within one of London’s most sought-after residential areas
Claret Capital Partners, a London-based independent growth debt fund manager, has officially closed its Claret European Growth Capital Fund IV, raising a total of €575 million. This surpasses the €500 million initial target set for Fund IV. The €575 million sum consists of €440 million committed to Fund IV and €135 million invested in an affiliated discretionary mandate.
The firm attributes this impressive fundraising to increased commitments from its institutional investor base, as well as private wealth investors through an ELTIF structure. Fund IV builds upon Claret's impressive track record, with total capital raised since inception totaling €1.3 billion. David Bateman, Managing Partner at Claret Capital Partners, emphasizes that this raised capital validates the firm's approach and track record, while also serving as a strong endorsement for the European technology, life sciences, and impact ecosystems.
Since 2013, Claret has invested over €1.5 billion across more than 210 companies in these sectors. The firm's team has been active in technology financing markets for over 25 years, offering debt solutions to help entrepreneurs and their investors grow while minimizing dilution. Loans typically range from €2 million to €100 million, tailored to each opportunity on a case-by-case basis.
As of now, 32% of Fund IV has already been deployed to support 27 companies, including Billie, Cinclus Pharma, PRODA, Inventiva, and Surfe. The firm is poised to continue its expansion, with a growing pipeline of high-quality investment opportunities and new team members based in Paris and Berlin.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
